Posted by iforgotmypassword on November 8, 2007, at 17:59:06
i'm very happy. it has arrived at my doctor's office, in surprisingly mass quantity. i pick it up at my appointment tomorrow at 10. my doctor was able to get it approved for me through Canada's federal "Special Access Programme."
this came really quickly, considering his direct correspondance with the company's branch (Sanofi-Aventis) in Laval (i'm on Ottawa) was earlier this week.
initially, along with the programme's approval of the drug, they sent this strange letter asking for my doctor to accept the documented cardiac/sudden risks associated with the drug, which he found a little disconcerting and was reluctant to go forward with prescribing the drug without further information. no sources were cited in the letter. later, research both me and my doctor found completely disagreed with the letter, saying amisulpride is among the antipsychotics with the least cardiac risk and AP associated cardiac effects, and no deaths have ever been reported (except in overdose, as i found in other articles.)
i certainly find the existence of the letter suspicious... drug company marketing-government drama? or north american psychiatric lack of sympathy for negative symptoms or dysthymia, etc. (seen more as character faults,) or an innocent lack of research and a letter that goes with any unapproved antispychotic asked for... who knows?
anyway, that's all i have to share for now. looking forward.
poster:iforgotmypassword
thread:793968
URL: http://www.dr-bob.org/babble/20071104/msgs/793968.html